Genetics Institute
Gainesville
About Genetics Institute
Genetics Institute is a U.S. based biotechnology research and development company. The company developed drugs such as Neumega and Recombinate used in the prevention of severe reductions in the number of blood clotting cells. The company was founded in 1980 by Thomas Maniatis and Mark Ptashne, and started off by operating out of Ptashne’s home. Genetics Institute was acquired by Wyeth in 1992 and operates as part of Wyeth’s research division.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Estimated revenue: $100K – $500K
- Funding stage: M&A
- Last round: Seed (Jan 1980)
- Website: ufgi.ufl.edu
- Phone: +1 352-273-8100
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/genetics-institute-1298191 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.